The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures. The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of patients willing to consent as measured by enrollment log
Timeframe: End of Study, 12 months
Proportion of patients willing to participate as measured by enrollment log
Timeframe: End of Study, 12 months
Rate of completion of questionnaire measures as measured by Research Electronic Data Capture (REDCAP)
Timeframe: End of Study, 12 months
Rate of Patient Decision Support tool delivery and data capture as measured by web based data capture
Timeframe: End of Study, 12 months
Percent of patients who stated that the intervention was acceptable as measured by patient and provider interviews.
Timeframe: 1 week post clinic visit